These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1415465)

  • 41. Vitreoretinal complications of the Boston Keratoprosthesis.
    Modjtahedi BS; Eliott D
    Semin Ophthalmol; 2014; 29(5-6):338-48. PubMed ID: 25325859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of single-drop mitomycin C regime with other mitomycin C regimes in pterygium surgery.
    Gupta VP; Saxena T
    Indian J Ophthalmol; 2003 Mar; 51(1):59-65. PubMed ID: 12701864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ocular and cutaneous effects of chronic phenothiazine therapy.
    Bond WS; Yee GC
    Am J Hosp Pharm; 1980 Jan; 37(1):74-8. PubMed ID: 6102438
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparison between the role of intraoperative mitomycin C and doxorubicin in preventing the recurrence of primary pterygium.
    Sodhi PK; Verma L; Pandey RM; Ratan S
    Ophthalmic Res; 2005; 37(1):1-6. PubMed ID: 15604592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retinal detachment with proliferative vitreoretinopathy: surgical results with scleral buckling, closed vitrectomy, and intravitreous air injection.
    Ho PC; McMeel JW
    Br J Ophthalmol; 1985 Aug; 69(8):584-7. PubMed ID: 4016057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of recurrent pterygium with intraoperative mitomycin C and conjunctival autograft with fibrin glue.
    Shehadeh-Mashor R; Srinivasan S; Boimer C; Lee K; Tomkins O; Slomovic AR
    Am J Ophthalmol; 2011 Nov; 152(5):730-2. PubMed ID: 21742307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanophthalmic uveal effusion managed with scleral windows and topical mitomycin-C.
    Akduman L; Adelberg DA; Del Priore LV
    Ophthalmic Surg Lasers; 1997 Apr; 28(4):325-7. PubMed ID: 9101574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postoperative instillation of mitomycin C in the treatment of recurrent pterygium.
    Hayasaka S; Noda S; Yamamoto Y; Setogawa T
    Ophthalmic Surg; 1989 Aug; 20(8):580-3. PubMed ID: 2506499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitreoretinal and anterior segment surgery through the pars plana: Part II.
    Michels RG
    Ann Ophthalmol; 1976 Dec; 8(12):1497-1502, 1504-12. PubMed ID: 1015744
    [No Abstract]   [Full Text] [Related]  

  • 50. Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium.
    Rachmiel R; Leiba H; Levartovsky S
    Br J Ophthalmol; 1995 Mar; 79(3):233-6. PubMed ID: 7703200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Corneal complications of intraoperative Mitomycin C in glaucoma surgery.
    Coppens G; Maudgal P
    Bull Soc Belge Ophtalmol; 2010; (314):19-23. PubMed ID: 20480747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intraoperative application of topical mitomycin C 0.05% for pterygium surgery.
    Rodriguez JA; Ferrari C; Hernández GA
    Bol Asoc Med P R; 2004; 96(2):100-2. PubMed ID: 15580913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Corneal/scleral thinning and corticosteroids.
    Mackool RJ
    J Cataract Refract Surg; 2010 Nov; 36(11):2018. PubMed ID: 21029929
    [No Abstract]   [Full Text] [Related]  

  • 54. Detection of ciliary body detachment with anterior segment optical coherence tomography.
    Burés-Jelstrup A; Navarro R; Mateo C; Adan A; Corcóstegui B
    Acta Ophthalmol; 2008 Nov; 86(7):810-1. PubMed ID: 18221496
    [No Abstract]   [Full Text] [Related]  

  • 55. Effectiveness of intraoperative mitomycin C in the treatment of recurrent pterygium.
    Mastropasqua L; Carpineto P; Ciancaglini M; Lobefalo L; Gallenga PE
    Ophthalmologica; 1994; 208(5):247-9. PubMed ID: 7816415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Ocular side effects of drugs].
    Müller-Breitenkamp U; Hockwin O
    Laryngorhinootologie; 1992 Apr; 71(4):226-8. PubMed ID: 1575856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tamoxifen-associated eye disease. A review.
    Nayfield SG; Gorin MB
    J Clin Oncol; 1996 Mar; 14(3):1018-26. PubMed ID: 8622006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monitoring corneal densities following primary pterygium excision with adjuvant topical mitomycin-C application--an observational study of corneal scar changes.
    Kam KW; Belin MW; Young AL
    Cornea; 2015 May; 34(5):530-4. PubMed ID: 25768386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pulse-mode mitomycin C use in pterygium surgery.
    Sakarya Y; Sakarya R
    Am J Ophthalmol; 2009 Sep; 148(3):475-6; author reply 476. PubMed ID: 19703617
    [No Abstract]   [Full Text] [Related]  

  • 60. Tamoxifen-induced ocular toxicity.
    Mihm LM; Barton TL
    Ann Pharmacother; 1994 Jun; 28(6):740-2. PubMed ID: 7919565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.